These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12082764)

  • 21. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Bartlett RH
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():22-3. PubMed ID: 16215890
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation.
    Isoniemi H; Koivusalo AM; Repo H; Ilonen I; Höckerstedt K
    Transplant Proc; 2005 Mar; 37(2):1088-90. PubMed ID: 15848631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.
    Krisper P; Haditsch B; Stauber R; Jung A; Stadlbauer V; Trauner M; Holzer H; Schneditz D
    J Hepatol; 2005 Sep; 43(3):451-7. PubMed ID: 16023249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artificial liver support devices for fulminant liver failure.
    Sechser A; Osorio J; Freise C; Osorio RW
    Clin Liver Dis; 2001 May; 5(2):415-30. PubMed ID: 11385970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.
    Karvellas CJ; Gibney N; Kutsogiannis D; Wendon J; Bain VG
    Crit Care; 2007; 11(3):215. PubMed ID: 17567927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
    Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
    ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal techniques in the treatment of poisoned patients.
    Pond SM
    Med J Aust; 1991 May; 154(9):617-22. PubMed ID: 2056948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
    Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
    Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful hemoperfusion and plasma exchange in acute hepatic failure due to snake bile intoxication.
    Hong SM; Tai DI; Wu MS; Lin JL
    Chang Gung Med J; 2008; 31(2):207-11. PubMed ID: 18567422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning.
    Kantola T; Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):399-403. PubMed ID: 19788456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective plasma exchange with dialysis in patients with acute liver failure.
    Nakae H; Igarashi T; Tajimi K
    Ther Apher Dial; 2012 Oct; 16(5):467-71. PubMed ID: 23046372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel plasma filtration therapy for hepatic failure: preclinical studies.
    Rozga J; Umehara Y; Trofimenko A; Sadahiro T; Demetriou AA
    Ther Apher Dial; 2006 Apr; 10(2):138-44. PubMed ID: 16684215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of double-filtration plasmapheretic cross-circulation with a high-permeability membrane using canine harvested liver in porcine fulminant hepatic failure model.
    Ishizawa Y; Totsuka E; Umehara M; Nishimura A; Ono H; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2344-8. PubMed ID: 15561244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute-on-chronic liver failure: extracorporeal liver assist devices.
    Hassanein TI; Schade RR; Hepburn IS
    Curr Opin Crit Care; 2011 Apr; 17(2):195-203. PubMed ID: 21346566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction of disturbed pathophysiology of hepatic failure by albumin dialysis.
    Williams R
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):19-24. PubMed ID: 18234633
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
    Oettl K; Stadlbauer V; Krisper P; Stauber RE
    Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of sorbent columns and haemofiltration in fulminant hepatic failure.
    Hughes RD; Williams R
    Blood Purif; 1993; 11(3):163-9. PubMed ID: 8280438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorbent-based artificial liver devices: principles of operation, chemical effects and clinical results.
    Carpentier B; Ash SR
    Expert Rev Med Devices; 2007 Nov; 4(6):839-61. PubMed ID: 18035950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver replacement therapy. Reliable indications in acute liver failure].
    Rifai K; Ott M; Bahr MM; Schneider A; Manns MP
    Internist (Berl); 2003 Dec; 44(12):1485-90. PubMed ID: 14689190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.